Tardive Dyskinesia in Patients Receiving Continuous Versus Intermittent Oral Metoclopramide: A Retrospective Real World Study. [PDF]
Russo P, Nathan R, Camilleri M.
europepmc +1 more source
Psychometric Properties of Instruments to Assess Movement Disorders in People With Intellectual Disabilities Using Antipsychotics: A Systematic Literature Review. [PDF]
Hoekstra-van Duijn MLD +4 more
europepmc +1 more source
Dopamine trasporter reversal as a pathogenic mechanism for L-dopa induced dyskinesia
L-dopa remains the most effective drug for improving motor symptoms of Parkinson's disease (PD). However, following long-term chronic treatment, the therapeutic effects of L-dopa are often accompanied by debilitating peak-dose dyskinesia.
Cheng, Christina
core
Emergency Department Presentation of Duloxetine-induced Acute Extrapyramidal Symptoms: A Case Report. [PDF]
Shulby MW, Powell CM.
europepmc +1 more source
Epilepsy-Related Psychosis in Drug-Resistant Epilepsy With Nonconvulsive Status Epilepticus and Difficult Antipsychotic Titration: A Case Report. [PDF]
Omori W +4 more
europepmc +1 more source
A novel approach to the management of levodopa-induced dyskinesia using deep transcranial magnetic stimulation: A case report. [PDF]
Song IU, Kim B, Chung YA.
europepmc +1 more source
Lithium-induced blepharospasm in a middle-aged woman with recurrent depressive disorder: a case report. [PDF]
Arevalo Bazalar MDR, De Silva J.
europepmc +1 more source
Tardive Dyskinesia Induced by Long-Acting Injectable Paliperidone Palmitate Once Every 3 Months in a Patient With Schizophrenia: A Case Report and Literature Review. [PDF]
Ge J, Li J, Ma R, Tong L, Bo Q, Zhang Z.
europepmc +1 more source
Tomoyoshi, Kondo, Hiroshi, Ishiguchi
openaire +1 more source
Response to [Time zero alignment in target trial emulation of VMAT2 inhibitors versus anticholinergics for tardive dyskinesia]. [PDF]
Hsu TW, Tsai CK, Liang CS.
europepmc +1 more source

